p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells-Reference-Cited by-同舟云学术

p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

Published:2012-06-18 Issue:7 Volume:14 Page:870-881
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Cen L.,Carlson B. L.,Schroeder M. A.,Ostrem J. L.,Kitange G. J.,Mladek A. C.,Fink S. R.,Decker P. A.,Wu W.,Kim J.-S.,Waldman T.,Jenkins R. B.,Sarkaria J. N.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/14/7/870/3800646/nos114.pdf

Reference19 articles.

1. An Integrated Genomic Analysis of Human Glioblastoma Multiforme

2. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

3. A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumor Growth by Specific Inhibition of Cyclin-Dependent Kinase 4/6

4. Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of precision oncology in adult glioblastoma;Molecular Oncology;2024-06-20

2. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets;The FASEB Journal;2024-06-07

3. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-05-08

4. Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review;Breast Cancer: Targets and Therapy;2024-04

5. Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance;International Journal of Clinical and Experimental Pathology;2024